 |
|
Phototoxic Reactions to Photoactive Drugs in Patients Treated With PUVA
Robert S. Stern, MD;
Ruth A. Kleinerman, MPH;
John A. Parrish, MD;
Thomas B. Fitzpatrick, MD;
Howard L. Bleich, MD
Arch Dermatol. 1980;116(11):1269-1271.
Abstract
• To determine the potentially adverse effects of photoactive medications taken in conjunction with oral methoxsalen photochemotherapy (PUVA) for psoriasis, we studied the incidence of phototoxic reactions in 1,125 patients treated with PUVA at 15 centers. During the initial (clearing) phase of PUVA therapy, patients using photoactive medications were no more likely to have diffuse delayed erythema than patients who did not use such medications. After clearing, patients 45 years of age or older who used photoactive drugs were 2.3 times as likely to discontinue PUVA therapy for at least one month owing to problems related to UV-induced burns than were those who did not use such drugs. Only 6% of patients older than 45 years who took photoactive medications had problems with phototoxicity sufficiently severe to contribute to permanent discontinuation of PUVA therapy.
(Arch Dermatol 116:1269-1271, 1980)
Author Affiliations
From the Department of Dermatology, Massachusetts General Hospital (Drs Parrish, Fitzpatrick, and Kleinerman); and the Departments of Dermatology (Dr Stern) and the Computer Medicine Laboratory and Department of Medicine (Dr Bleich), Beth Israel Hospital and Harvard Medical School, Boston.
Footnotes
Accepted for publication March 4, 1980.
Reprint requests to Department of Dermatology, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215 (Dr Stern).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Psoralen and Ultraviolet A Light Therapy for Psoriasis
Stern
NEJM 2007;357:682-690.
FULL TEXT
Adverse Drug Interactions Clinically Important for the Dermatologist
Andersen and Feingold
Arch Dermatol 1995;131:468-473.
ABSTRACT
|
